Europe Clears Roche Cancer Drug After Contamination Report
A European Medicines Agency committee said Friday that problems surrounding bacterial contamination of Roche Holding AG cancer drug MabThera have been resolved and that the tainted product never posed a direct...To view the full article, register now.
Already a subscriber? Click here to view full article